We and others have identified links between BPA exposure and glucose and lipid metabolism disorders both in vitro and in vivo.[2] BPA is best known for its estrogenicity, having been demonstrated to bind to classical estrogen receptors (ERs), namely, ERα and ERβ, androgen receptor, as well as to nonclassical plasma membrane‐bound ERs such as the G‐protein‐coupled receptor 30 (GPR30). This evidence concerns the gene ESR1 and Disorder of lipid metabolism.